In order to clone the D1 dopamine receptor linked to adenylyl cyclase activation, the polymerase chain reaction was used with highly degenerate primers to selectively amplify a cDNA sequence from NS20Y neuroblastoma cell mRNA. This amplification produced a cDNA fragment exhibiting considerable sequence homology to guanine nucleotidebinding (G)-protein-coupled receptors that have been cloned previously. To characterize this cDNA further, a full-length clone was isolated from a rat striatal library by using the cDNA fragment as a probe. Sequence analysis of this cDNA clone indicated that it is indeed a member of the G-protein-coupled receptor family and exhibits greatest homology with the
Dopamine receptors belong to a large superfamily of receptors that are linked to their signal-transduction pathways via guanine nucleotide-binding regulatory (G) proteins. Pharmacological, biochemical, and physiological criteria have been used to describe two subcategories of dopamine receptors referred to as D1 and D2 (1) . D1 receptors have been classically defined as being linked to the stimulation of adenylyl cyclase activity (2, 3) . In contrast, activation of D2 receptors results in various responses (4) , including inhibition of adenylyl cyclase activity, inhibition of phosphatidylinositol turnover, increase in K+ channel activity, and inhibition of Ca2+ mobilization. The molecular characterization of D2 dopamine receptors has been facilitated by the cloning of a cDNA encodin.g a rat D2 receptor (5) . More recently, this receptor has been shown to exist as two protein isoforms that are derived from a single gene yet produced by alternative RNA splicing (6) (7) (8) (9) (10) (11) . This splice variation occurs in a region of the receptor that may be involved in G-protein coupling, suggesting that these receptor isoforms may activate different signal-transduction pathways.
Evidence has also accumulated suggesting heterogeneity in the D1 category of dopamine receptors. D1 receptors have recently been described in renal tissue that stimulate phospholipase C activity independently from that of adenylyl cyclase (12) (13) (14) . We have shown, using Xenopus oocyte expression experiments, that rat striatal mRNA encodes D1 receptors that are coupled to phospholipase C and Ca2+ mobilization in a cAMP-independent fashion (15) . These data suggest that there may be multiple D1 receptors linked to different signal-transduction pathways or that a single, multifunctional D1 receptor exists. To investigate these possibilities and to characterize the D1 receptor(s) on a molecular level, we have attempted to clone the D1 receptor subtype expressed in mouse NS20Y neuroblastoma cells, which is coupled to the stimulation of cAMP generation (16) . § METHODS Polymerase Chain Reaction (PCR). Poly(A)+ RNA was prepared from NS20Y cells exactly as described (15) . Firststrand cDNA synthesis was performed using this RNA template in the presence of avian myeloblastosis virus reverse transcriptase (Promega) and 1 ,g of oligo(dT) primer. This cDNA was then submitted to 30 cycles of PCR amplification in a total volume of 100 ,ul with 1 ,uM each of the oligodeoxynucleotide primers 5'-GTCGACCCTGTGC(or T)GC(or T)C(or G)ATCAG(or C)CATG(or T)GAT(or C)C(or A)GC(or G)TA-3' and 3'-AAGT(or C)G(or A)G(or C)G(or T)AGAC-GACCG(or A)AC(or G)GGGAAGAAGT(or A)ATTCGAA-5' in the presence of Thermus aquaticus (Taq) DNA polymerase (Perkin-Elmer/Cetus). The timing used was 1.5 min at 93°C, 2 min at 55°C, and 4 min at 72°C followed by a 7-min extension at 72°C. Individual bands were isolated by gel electrophoresis and subcloned into pGEM-9Zf(-) (Promega). Minipreparations of plasmid DNA were prepared for insert sequencing as described below.
cDNA Library Screening and DNA Sequencing. A rat striatal cDNA library constructed in the A ZAP II vector (Stratagene) was screened (6) with a PCR fragment that was 32P-labeled by nick-translation. High-stringency washing of the filters was performed with 0.15 M NaCl/0.015 sodium citrate, pH 7/0.1% SDS at 65°C prior to autoradiography. A phage found to hybridize to the probe were subsequently plaque-purified. In vivo excision and rescue of the nested pBluescript plasmids from the A ZAP II clones were performed according to the Stratagene protocol. Nucleotide Abbreviations: G protein, guanine nucleotide-binding protein; PCR, polymerase chain reaction. tTo whom reprint requests should be addressed. §The sequence reported in this paper has been deposited in the GenBank data base (accession no. M35077).
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TM-V HAT DIR:
11UM a 2AR: Expression Studies. A full-length cDNA insert, including the multiple cloning site of the A ZAP II vector, was amplified from the purified A phage clone by using T3 and T7 promoter primers and PCR as described above. The reaction product was subcloned into the Not I/Kpn I restriction sites in a modified expression vector, pCD-SRa (17). This construct was used to transiently transfect COS-7 cells by the calcium phosphate precipitation technique (18) . After 72 hr, membranes were prepared and assayed for D1 receptor binding activity with [3H]SCH-23390 (DuPont/NEN) exactly as described (16) . Intact cells were used for cAMP assays (19) . Protein concentrations were determined using the bicinchoninic acid (BCA) reagent (Pierce) as described (20) .
RESULTS AND DISCUSSION
To clone the D1 dopamine receptor linked to adenylyl cyclase activation, we used the PCR method to selectively amplify cDNA sequences from mRNA purified from mouse NS20Y neuroblastoma cells, which express this receptor subtype (16) . Poly(A)+ RNA was used to synthesize cDNA by reverse transcription and this cDNA was subjected to PCR amplification with a pair of highly degenerate primers derived from the third and sixth transmembrane regions of the previously cloned adrenergic, D2 dopamine, and serotonin receptors. This process resulted in the amplification of several cDNA fragments, which were preliminarily characterized by DNA sequence analysis (data not shown). One of these fragments exhibited considerable sequence homology to previously cloned G-protein-coupled receptors and was used to screen a rat striatal cDNA library in order to isolate a full-length clone. One clone (pB73D1) with an insert of -3.6 kilobases (kb) was isolated and found to hybridize strongly with the 32P-labeled PCR probe on dot blot analysis (data not shown).
The nucleotide sequence of this cDNA exhibited >90% homology in the region of the PCR fragment, the divergence of which is probably attributable to species differences (mouse vs. rat).
The complete nucleotide and deduced amino acid sequence for clone pB73D1 is shown in Fig. 1A . The longest open reading frame in this cDNA codes for a 487-residue protein of 54,264 Da. Although the neighboring sequence of the first ATG in this reading frame is similar to Kozak's consensus initiation sequence (23), the third methionine codon, at position 46, actually provides a better match (Fig. 1A) . Additional work will thus be necessary to definitively assign the translational start site for this mRNA. Hybridizations were performed using 32P-labeled oligonucleotides as described (Methods and ref. terminus is proposed to be extracellular and the COOH terminus projects into the cytoplasm (24) . The NH2 terminus contains one consensus site for N-linked glycosylation, while the predicted third cytoplasmic loop exhibits one consensus recognition site for phosphorylation by the cAMP-dependent protein kinase (Fig. 1A) . In addition, the long COOH terminus contains several serine and threonine residues possibly representing additional sites for regulatory phosphorylation (25) .
Comparison of the deduced amino acid sequence for the pB73D1 cDNA clone with the sequences of various catecholamine receptors (Fig. 1B) shows that the regions of highest identity occur within the predicted transmembrane domains. Within these regions, the pB73D1 protein exhibits sequence homologies of 44% with the rat D2 dopamine receptor; 44%, 43%, and 40% with the human f3-, 12-, and /33-adrenergic receptors, respectively; and 43% and 42% with the hamster alB-and human a2A-adrenergic receptors, respectively. When compared with various serotonin receptors, the transmembrane regions of the pB73D1 protein exhibited homologies of 40% for 5HT1A and 37% for both 5HT1c and 5HT2 receptors (data not shown). The NH2 and COOH termini and the extracellular and intracellular loops are significantly more divergent among these receptors. It is interesting that within the third putative transmembrane domain of pB73D1, there is a conserved aspartic residue that is common to all biogenic amine receptors that have been sequenced thus far (26) . Moreover, the fifth transmembrane domain of pB73D1 also contains two serine residues that are conserved among catecholamine receptors and are critical for the recognition of agonist ligands possessing a catechol group (x6.5.) (B) High magnification darkfield photomicrograph showing silver grains (white dots) overlying medium-size neurons in the striatum generated by in situ hybridization labeling of D1 receptor mRNA. About half of the medium-size neurons in this field of the striatum are labeled (arrows), which is typical of the striatum as a whole. (x150.) (26) . These observations suggest the pB73D1 clone encodes a receptor for an endogenous catecholamine ligand.
In an initial attempt to establish the identity of pB73D1, we analyzed the tissue distribution of its corresponding mRNA by Northern blot and in situ hybridization analyses. Northern blot analysis (Fig. 2 ) of various neural tissues reveals a transcript of =4 kb that is predominantly located in the striatum with lesser amounts in the cortex and retina. In contrast, no mRNA is observed in the cerebellum, hippocampus, olfactory bulb, mesencephalon, or pituitary. In situ hybridization also indicates a high abundance of mRNA in the striatum as well as in the olfactory tubercle (Fig. 3A) . Approximately half of the medium-sized neurons in the striatum are identified by this technique (Fig. 3B) . The tissue distribution of pB73D1 mRNA exhibited in Figs. 2 and 3 is remarkably similar to that of the D1 dopamine receptor as demonstrated by receptor binding and autoradiography studies (1) .
To definitively establish the identity of the receptor encoded by the pB73D1 clone, the cDNA insert was subcloned into the pCD-SRa vector (17) for expression in eukaryotic cells. The resulting plasmid, pSRa-D1, was used to transiently transfect COS-7 cells. Fig. 4A shows that [3H]SCH-23390, a Dl-selective radiolabeled antagonist, binds to COS-7 membranes in a saturable fashion with high specific activity (-400 fmol/mg of protein) and an affinity (0.3 ± 0.03 nM) in good agreement with that found in the rat striatum (1) . No specific binding is detected in COS-7 cells that have not been transfected with pSRa-D1 or that have been transfected with the pCD-SRa vector alone (data not shown). Proc. Natl. Acad Sci. USA 87 (1990) pSRa-D1-transfected COS-7 cells also exhibit D1 receptormediated stimulation of cAMP production. Dopamine stimulates cAMP production -2-fold in these transfected cells (Fig. 5) . In contrast, no response to dopamine is observed in nontransfected cells (data not shown). The D1-selective agonists (+)-SKF-38393 and (+)-SKF-82958 stimulate cAMP accumulation to a similar extent as dopamine. Although SKF-38393 has been reported to be a partial agonist at D1 receptors, its fuller efficacy observed here is probably due to the presence of spare receptors resulting from overexpression of receptor protein. In addition, the stimulation by SKF-38393 exhibits appropriate stereoselectivity, with the (-) isomer exhibiting a lower potency (Fig. 5) . Finally, the f3-adrenergic agonist epinephrine also exhibits a low potency relative to dopamine, as expected for a D1 receptor. In these experiments, the f3-adrenergic antagonist propranolol was included in the assays to preclude stimulation of the endogenous COS-7 cell f-adrenergic receptor. These expression data thus confirm that the cDNA which we have cloned encodes a functional D1 dopamine receptor protein.
It is important to emphasize that the D1 receptor that we have cloned is functionally coupled to the stimulation of adenylyl cyclase. Recently, unique D1 receptors have been described in kidney that stimulate phospholipase C activity independently from the activation of adenylyl cyclase (12) (13) (14) . We previously showed, using Xenopus oocyte expression experiments, that rat striatum contains mRNA encoding D1 receptors that can couple to phospholipase C, inositol phosphate production, and Ca2+ mobilization in a cAMPindependent fashion (15) . It is interesting that the mRNA encoding this D1 receptor-stimulated phospholipase C response is -2.5 kb long (15) , in comparison with the -4-kb D1 receptor mRNA observed here. Moreover, in preliminary experiments, we have found that when mRNA is transcribed from the pB73D1 D1 receptor cDNA clone and injected into Xenopus oocytes, dopamine will stimulate cAMP accumulation =2-fold but is incapable of producing a Ca2+ mobilization response (unpublished observations). These findings suggest that the striatum contains two separate D1 receptor proteins that are coupled to different signal-transduction pathways. Consequently, we propose that the D1 receptor subtypes linked to the activation of adenylyl cyclase and phospholipase C be designated D1A and D1B, respectively. Further experimentation involving the cloning and expression of the D1B receptor subtype will be required to confirm this hypothesis.
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